ICD; Defibrillation
References
US Food and Drug Administration. FDA Issues Nationwide Notification of Recall of Certain Guidant Implantable Defibrillators and Cardiac Resynchronization Therapy Defibrillators. Rockville, MD: National Press Office; June 17, 2005. Paper P05-29.
Al-Khatib SM, Anstrom KJ, Eisenstein EL, et al. Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II. Ann Intern Med. 2005 Apr 19;142(8):593-600.
Goldstein NE, Lampert R, Bradley E, Lynn J, Krumholz HM. Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med. 2004 Dec 7;141(11):835-8.
Review Date: 07/12/2006
Reviewed By: Glenn Gandelman, MD, MPH, Assistant Clinical Professor of Medicine,
New York Medical College, Valhalla, NY. Review provided by VeriMed
Healthcare Network.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org)
